Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results
Authors:
- 1 October 2017
- journal article
- Published by Elsevier in Hand Surgery and Rehabilitation
- Vol. 36 (5) , 346-349
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Percutaneous Aponeurotomy and Lipofilling (PALF) versus Limited Fasciectomy in Patients with Primary Dupuytren’s Contracture: A Prospective, Randomized, Controlled TrialPlastic and Reconstructive Surgery, 2016
- Needle Aponeurotomy for the Treatment of Dupuytren’s DiseaseHand Clinics, 2014
- Advances in the Management of Dupuytren DiseaseHand Clinics, 2012
- Five-Year Results of a Randomized Clinical Trial on Treatment in Dupuytrenʼs DiseasePlastic and Reconstructive Surgery, 2012
- Wnt Signaling and Dupuytren's DiseaseNew England Journal of Medicine, 2011
- Percutaneous Fasciotomy for Dupuytren's ContractureThe Journal of Hand Surgery, 2011
- Injectable Collagenase Clostridium Histolyticum: A New Nonsurgical Treatment for Dupuytren's DiseaseThe Journal of Hand Surgery, 2010
- Injectable Collagenase Clostridium Histolyticum for Dupuytren's ContractureNew England Journal of Medicine, 2009
- Efficacy and Safety of Injectable Mixed Collagenase Subtypes in the Treatment of Dupuytren’s ContractureThe Journal of Hand Surgery, 2007
- Prediction of recurrence in the treatment of Dupuytren's disease: Evaluation of a histologic classificationThe Journal of Hand Surgery, 1989